Cargando…
An ANN model for treatment prediction in HBV patients
Two types of antiviral treatments, namely, interferon and nucleoside/nucleotide analogues are available for hepatitis infections. The selection of drug and dose determined using known pharmacokinetics and pharmacodynamics data is important. The lack of sufficient information for pharmacokinetics of...
Autores principales: | Iqbal, Sajid, Masood, Khalid, Jafer, Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124792/ https://www.ncbi.nlm.nih.gov/pubmed/21738322 |
Ejemplares similares
-
Distinguishing compounds with anticancer activity by ANN using inductive QSAR descriptors
por: Jaiswal, Kunal, et al.
Publicado: (2008) -
Early diagnosis of systemic lupus erythmatosus using ANN models of dsDNA binding antibody sequence data
por: Bahari, Mohamad Hasan, et al.
Publicado: (2010) -
The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases
por: Zhang, Xiaonan, et al.
Publicado: (2022) -
A QSAR study on some series of antihepatitis B virus (HBV) agents
por: Arora, Preet K, et al.
Publicado: (2010) -
Moderate ischemic mitral regurgitation (IMR) and metabolic syndrome: where are we now and where are we going?
por: Osman, Khalid A, et al.
Publicado: (2006)